Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1 		0.400 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 1535
Gene Symbol: CYBA
CYBA 		0.400 Biomarker phenotype CTD_human Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. 28108177 2017
Entrez Id: 55315
Gene Symbol: SLC29A3
SLC29A3 		0.400 Biomarker phenotype CTD_human Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. 20140240 2010
Entrez Id: 9719
Gene Symbol: ADAMTSL2
ADAMTSL2 		0.400 Biomarker phenotype CTD_human ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. 18677313 2008
Entrez Id: 5184
Gene Symbol: PEPD
PEPD 		0.400 Biomarker phenotype CTD_human A nonsense mutation of PEPD in four Amish children with prolidase deficiency. 16470701 2006
Entrez Id: 4591
Gene Symbol: TRIM37
TRIM37 		0.400 Biomarker phenotype CTD_human Mulibrey nanism: clinical features and diagnostic criteria. 14757854 2004
Entrez Id: 5184
Gene Symbol: PEPD
PEPD 		0.400 Biomarker phenotype HPO
Entrez Id: 9719
Gene Symbol: ADAMTSL2
ADAMTSL2 		0.400 Biomarker phenotype HPO
Entrez Id: 4591
Gene Symbol: TRIM37
TRIM37 		0.400 Biomarker phenotype HPO
Entrez Id: 55315
Gene Symbol: SLC29A3
SLC29A3 		0.400 Biomarker phenotype HPO
Entrez Id: 1535
Gene Symbol: CYBA
CYBA 		0.400 CausalMutation phenotype CLINVAR
Entrez Id: 1535
Gene Symbol: CYBA
CYBA 		0.400 Biomarker phenotype HPO
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1 		0.400 Biomarker phenotype HPO
Entrez Id: 4846
Gene Symbol: NOS3
NOS3 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 213
Gene Symbol: ALB
ALB 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 114757
Gene Symbol: CYGB
CYGB 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 9817
Gene Symbol: KEAP1
KEAP1 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4843
Gene Symbol: NOS2
NOS2 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 2494
Gene Symbol: NR5A2
NR5A2 		0.300 Biomarker phenotype CTD_human LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity. 29515023 2018
Entrez Id: 5970
Gene Symbol: RELA
RELA 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 1432
Gene Symbol: MAPK14
MAPK14 		0.300 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 3953
Gene Symbol: LEPR
LEPR 		0.300 Biomarker phenotype CTD_human Increased susceptibility to troglitazone-induced mitochondrial permeability transition in type 2 diabetes mellitus model rat. 29743445 2018
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1 		0.300 Biomarker phenotype CTD_human Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. 28108177 2017
Entrez Id: 246329
Gene Symbol: STAC3
STAC3 		0.300 Biomarker phenotype CTD_human Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. 28108177 2017